Skip to content
Malawi Clinical GuidelinesGuidelinesGet app

25

Monitoring and evaluation

Clinical HIV Guidelines, 5th Edition, 2022. Chapter 25, Monitoring and evaluation.

Clinical description

  • The HIV program relies heavily on accurate and timely data for planning, reporting to donors

and for drug procurement and distribution.

  • Data analysis and reporting is done from patient cards and clinic registers at many facilities,

but electronic systems for monitoring are used at sites with many patients.

  • Reporting is done monthly for ANC, maternity and exposed child follow-up and quarterly for

ART (see Table 27 on page 122)

  • Cohort analyses are needed to report outcomes of patients in ANC, exposed child and ART

follow-up. Cohort reports look at the current / latest status of all patients enrolled in follow- up and require a review of all patient records to classify primary and secondary outcomes before data can be aggregated for reporting.

  • Complete facility reports within 5 working days after the end of the reporting period.
  • HIV Program reporting is integrated into the regular Health Management Information System.

Monthly / quarterly facility reports are entered directly into the District Health Information System at the District Health Offices for national reporting.

Check doses against the printed guideline and your clinical judgement before treating a patient. Spotted an error? Report it from the contact links below.

Need this without data?

The app holds every guideline on your device, with calculators, bookmarks and notes.